Bluejay Diagnostics (BJDX) Current Assets (2020 - 2026)

Bluejay Diagnostics' Current Assets history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Current Assets rose 11.07% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 11.07% YoY), while the FY2025 annual figure was $5.5 million, up 11.53% from the prior year.
• Current Assets came in at $4.0 million for Q1 2026 at Bluejay Diagnostics, down from $5.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $19.3 million in Q1 2022 to a low of $3.2 million in Q4 2023.
• A 5-year average of $7.8 million and a median of $6.5 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 326.99% in 2022 and sank 72.68% in 2023, its largest moves.
• Bluejay Diagnostics' Current Assets stood at $11.8 million in 2022, then tumbled by 72.68% to $3.2 million in 2023, then jumped by 52.1% to $4.9 million in 2024, then grew by 11.53% to $5.5 million in 2025, then slipped by 27.38% to $4.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $4.0 million, $5.5 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison